Varenicline, smoking cessation and neuropsychiatric adverse events

shutterstock_140803288

Varenicline is a prescription drug to help people stop smoking that works by stimulating the nicotine receptors in the brain to reduce cravings and decrease the pleasure that results from smoking. Quit attempts aided by varenicline are up to 2-3 times more successful than those without (Cahill et al 2009 and 2012). However, following the [read the full story…]

Quitting smoking is the easy part, staying quit is hard

shutterstock_99385985

During 2010/11 there were 1.53 million hospital admissions for illnesses directly attributable to smoking in the UK. These admissions, along with other smoking-related expenses, cost the NHS approximately £5 billion pounds per year. Fortunately, the NHS is spending £88.2 million per year on cessation treatments, many of which have been repeatedly demonstrated to be highly [read the full story…]

Using adaptive treatments for smoking cessation may prove effective

shutterstock_62480506

Around 20% of adults in the UK smoke cigarettes regularly. Smoking was the primary cause of approximately 462,900 hospital admissions and 79,100 (18%) deaths in adults over the age of 35 last year. Therefore, smoking cessation represents a serious (and costly!) clinical challenge on an individual and global level. Many smoking cessation aids are available, [read the full story…]

New Cochrane review finds that NRT, bupropion and varenicline are effective treatments for smoking cessation

Fist crushing cigarette packet

Smoking is the main preventable cause of premature illness and death worldwide. Approximately 20% of deaths in men and 5% in woman over 30 can be attributed to smoking. The World Health Organization (WHO) estimates that 6 million people die from smoking related disease each year, with tobacco being the number one risk factor for [read the full story…]

Cochrane review finds bupropion is the best treatment to help people with schizophrenia give up smoking

Woman breaking cigarette

People with schizophrenia are 2-3 times more likely to smoke tobacco than the rest of the population, so helping them quit is a significant public health issue. The evidence for smoking cessation interventions in the general population is fairly well defined. We know quite a bit about what works and we have a range of [read the full story…]

New evidence on drugs to help smokers quit

shutterstock_36041908

Some readers will be aware that the Mental Elf is no loner.  I have a number of elfin cousins who also run websites that help busy professionals keep up to date with the latest research, policy and guidance in their field. One such site is The Lifestyle Elf, and she has written a blog recently [read the full story…]